Literature DB >> 23407652

History, applications, and mechanisms of deep brain stimulation.

Svjetlana Miocinovic1, Suvarchala Somayajula, Shilpa Chitnis, Jerrold L Vitek.   

Abstract

Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory hypokinetic and hyperkinetic movement disorders, and it is being explored for a variety of other neurological and psychiatric diseases. Deep brain stimulation has been Food and Drug Administration-approved for essential tremor and Parkinson disease and has a humanitarian device exemption for dystonia and obsessive-compulsive disorder. Neurostimulation is the fruit of decades of both technical and scientific advances in the field of basic neuroscience and functional neurosurgery. Despite the clinical success of DBS, the therapeutic mechanism of DBS remains under debate. Our objective is to provide a comprehensive review of DBS focusing on movement disorders, including the historical evolution of the technique, applications and outcomes with an overview of the most pertinent literature, current views on mechanisms of stimulation, and description of hardware and programming techniques. We conclude with a discussion of future developments in neurostimulation.

Entities:  

Mesh:

Year:  2013        PMID: 23407652     DOI: 10.1001/2013.jamaneurol.45

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  110 in total

Review 1.  Network effects of deep brain stimulation.

Authors:  Ahmad Alhourani; Michael M McDowell; Michael J Randazzo; Thomas A Wozny; Efstathios D Kondylis; Witold J Lipski; Sarah Beck; Jordan F Karp; Avniel S Ghuman; R Mark Richardson
Journal:  J Neurophysiol       Date:  2015-08-12       Impact factor: 2.714

2.  Cellular mechanisms of deep brain stimulation: activity-dependent focal circuit reprogramming?

Authors:  Avin Veerakumar; Olivier Berton
Journal:  Curr Opin Behav Sci       Date:  2015-08-01

3.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

Review 4.  Neurostimulation in Alzheimer's disease: from basic research to clinical applications.

Authors:  Raffaele Nardone; Yvonne Höller; Frediano Tezzon; Monica Christova; Kerstin Schwenker; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  Neurol Sci       Date:  2015-02-27       Impact factor: 3.307

5.  Glial responses to implanted electrodes in the brain.

Authors:  Joseph W Salatino; Kip A Ludwig; Takashi D Y Kozai; Erin K Purcell
Journal:  Nat Biomed Eng       Date:  2017-11-10       Impact factor: 25.671

Review 6.  Current and emerging strategies for treatment of childhood dystonia.

Authors:  Matteo Bertucco; Terence D Sanger
Journal:  J Hand Ther       Date:  2014-11-15       Impact factor: 1.950

Review 7.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 8.  Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease.

Authors:  Sabato Santaniello; John T Gale; Sridevi V Sarma
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-20

Review 9.  Clinical neuroprosthetics: Today and tomorrow.

Authors:  Morgan B Lee; Daniel R Kramer; Terrance Peng; Michael F Barbaro; Charles Y Liu; Spencer Kellis; Brian Lee
Journal:  J Clin Neurosci       Date:  2019-07-30       Impact factor: 1.961

10.  The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS).

Authors:  Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Hernan D Gonorazky; Ivanna Yau; Cristina Go; Elizabeth Donner; Suneil K Kalia; Alfonso Fasano; Alexander G Weil; Aria Fallah; George M Ibrahim
Journal:  Childs Nerv Syst       Date:  2020-09-15       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.